nyvepria
pfizer europe ma eeig - пегфилграстин - Неутропения - Иммуностимуляторы, - Намаляване на продължителността на неутропения и честотата на фебрилна неутропения при възрастни пациенти, лекувани с цитотоксична химиотерапия за злокачествено заболяване (с изключение на хронична миелоидна левкемия и миелодиспластични синдроми).
tabic ib var206, effervescent tablets for suspension for chickens
phibro animal health (poland) sp. z o.o. - Вирус на инфекциозен бронхит по птиците (infectious bronchitis virus, ibv), вариант на щам 2-06, жив атенуиран - таблетка - не по-малко от 103,8 eid50 и не повече от 104,4 eid50* - пилета
vetaxam l.a. 150 mg/ml suspensionfor injection for cattle and pigs 150 mg/ml
vet-agro multi-trade company sp. z o. o. - Амоксицилин - инжекционна суспензия - 150 mg/ml - говеда, прасета
enhertu
daiichi sankyo europe gmbh - trastuzumab deruxtecan - Неоплазми на гърдата - Антинеопластични средства - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.
forespix 100 mg/ml solution for injection for cattle, pigs and sheep 100 mg/ml
vet-agro multi-trade company sp. z o. o. - Тулатромицин - инжекционен разтвор - 100 mg/ml - говеда, овце, свине
evrenzo
astellas pharma europe b.v. - roxadustat - anemia; kidney failure, chronic - Антианемични препарати - evrenzo is indicated for treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (ckd).
sitagliptin sun
sun pharmaceutical industries europe b.v. - sitagliptin fumarate - Захарен диабет тип 2 - Лекарства, използвани при диабет - for adult patients with type 2 diabetes mellitus, sitagliptin sun is indicated to improve glycaemic control:as monotherapy:- in patients inadequately controlled by diet and exercise alone and for whom metformin is inappropriate due to contraindications or intolerance. as dual oral therapy in combination with:- metformin when diet and exercise plus metformin alone do not provide adequate glycaemic control. - a sulphonylurea when diet and exercise plus maximal tolerated dose of a sulphonylurea alone do not provide adequate glycaemic control and when metformin is inappropriate due to contraindications or intolerance. - a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. a thiazolidinedione) when use of a pparγ agonist is appropriate and when diet and exercise plus the pparγ agonist alone do not provide adequate glycaemic control. as triple oral therapy in combination with:- a sulphonylurea and metformin when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. - a pparγ agonist and metformin when use of a pparγ agonist is appropriate and when diet and exercise plus dual therapy with these medicinal products do not provide adequate glycaemic control. sitagliptin sun is also indicated as add-on to insulin (with or without metformin) when diet and exercise plus stable dose of insulin do not provide adequate glycaemic control.
cibinqo
pfizer europe ma eeig - abrocitinib - Дерматит, Атопич - Други дерматологични препарати - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.
lumykras
amgen europe bv - sotorasib - Карцином, недребноклетъчен белодроб - Антинеопластични средства - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.
ngenla
pfizer europe ma eeig - somatrogon - growth and development - НА ХИПОФИЗАТА И ГИПОТАЛАМИЧЕСКИЕ ХОРМОНИ И АНАЛОЗИ - indicated for the long-term treatment of paediatric patients with growth disturbance due to insufficient secretion of growth hormone.